Cargando…

High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer

BACKGROUND AND OBJECTIVES: With increased neoadjuvant therapy recommendations for early‐stage breast cancer patients due to the COVID‐19 pandemic, it is imperative that molecular diagnostic assays provide reliable results from preoperative core needle biopsies (CNB). The study objective was to deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crozier, Jennifer A., Barone, Julie, Whitworth, Pat, Cheong, Abraham, Maganini, Robert, Tamayo, Jose Perez, Dauer, Patricia, Wang, Shiyu, Audeh, William, Glas, Annuska M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Breast
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305900/ https://www.ncbi.nlm.nih.gov/pubmed/34964996 http://dx.doi.org/10.1002/jso.26780

Ejemplares similares

Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
por: Whitworth, Pat, et al.
Publicado: (2022)

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
por: Whitworth, Pat W., et al.
Publicado: (2022)

A breast cancer gene signature for indolent disease
por: Delahaye, Leonie J. M. J., et al.
Publicado: (2017)

Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
por: Whitworth, Pat, et al.
Publicado: (2014)

Pathology Examination of Breast Reduction Specimens: Dispelling the Myth
por: Fisher, Mark, et al.
Publicado: (2020)

The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Blumencranz, Peter, et al.
Publicado: (2023)

Screen-detected and interval breast cancer after concordant and discordant interpretations in a population based screening program using independent double reading
por: Martiniussen, Marit A., et al.
Publicado: (2022)

Time Trends in Histopathological Findings in Mammaplasty Specimens in a Dutch Academic Pathology Laboratory
por: Stutterheim, Hannah W., et al.
Publicado: (2023)

Patient Self-reported Breast Cup Size and Resultant Mastectomy Specimen Weight: Implications for Reconstructive Breast Surgery
por: Perez, Kevin, et al.
Publicado: (2022)

Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
por: Whitworth, Pat W., et al.
Publicado: (2022)

Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient
por: Kim, Il-Kug, et al.
Publicado: (2020)

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial
por: Wolf, Denise M., et al.
Publicado: (2017)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

The 70-Gene Prognostic Signature for Korean Breast Cancer Patients
por: Na, Kuk Young, et al.
Publicado: (2011)

Undiagnosed Patent Foramen Ovale and Thrombophilic Gene Mutations Resulting in Pulmonary Embolism with Cryptogenic Stroke after Cosmetic Breast Surgery
por: Zaussinger, Maximilian, et al.
Publicado: (2023)

Robust interlaboratory reproducibility of a gene expression signature measurement consistent with the needs of a new generation of diagnostic tools
por: Ach, Robert A, et al.
Publicado: (2007)

Long-term impact of the 70-gene signature on breast cancer outcome
por: Drukker, C. A., et al.
Publicado: (2014)

Fresh Surgical Specimens Yield Breast Stem/Progenitor Cells and Reveal Their Oncogenic Abnormalities
por: Pommier, SuEllen J., et al.
Publicado: (2011)

Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations
por: Schwartzberg, Barbara, et al.
Publicado: (2018)

Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping
por: Whitworth, Pat, et al.
Publicado: (2016)

High-Resolution Full-3D Specimen Imaging for Lumpectomy Margin Assessment in Breast Cancer
por: Kulkarni, Swati A., et al.
Publicado: (2021)

Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature
por: Opdam, M., et al.
Publicado: (2022)

Breast Decisions: Recommender System for Appearance Counseling about Breast Reconstruction
por: Nicklaus, Krista M., et al.
Publicado: (2022)

Potential of Intraoperative 3D Photography and 3D Visualization in Breast Reconstruction
por: Nicklaus, Krista M., et al.
Publicado: (2021)

Predictors of Nipple–Areolar Complex Involvement by Breast Carcinoma: Histopathologic Analysis of 787 Consecutive Therapeutic Mastectomy Specimens
por: Wang, Jianli, et al.
Publicado: (2011)

Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
por: Baron, Paul, et al.
Publicado: (2015)

Tamoxifen therapy benefit for patients with 70-gene signature high and low risk
por: van ‘t Veer, Laura J., et al.
Publicado: (2017)

Diagnosis of a Malignant Intramammary Node Retrospectively Aided by Mastectomy Specimen MRI-Is the Search Worth It? A Case Report and Review of Current Literature
por: Mahajan, Abhishek, et al.
Publicado: (2013)

De-Implementation of Low-Value Care for Women 70 Years of Age or Older with Low-Risk Breast Cancer During the COVID-19 Pandemic
por: Wang, Ton, et al.
Publicado: (2023)

Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns
por: Goldhaber, Nicole H., et al.
Publicado: (2023)

Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature
por: Galamb, Orsolya, et al.
Publicado: (2008)

A 70-Gene Signature for Predicting Treatment Outcome in Advanced-Stage Cervical Cancer
por: Nguyen, Ngoc Ngo Yen, et al.
Publicado: (2020)

Improved identification of concordant and discordant gene expression signatures using an updated rank-rank hypergeometric overlap approach
por: Cahill, Kelly M., et al.
Publicado: (2018)

The Clinical Utility of DCISionRT(®) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery
por: Shah, Chirag, et al.
Publicado: (2021)

Concordant and discordant DNA methylation signatures of aging in human blood and brain
por: Farré, Pau, et al.
Publicado: (2015)

Impact of Non-Calcified Specimen Pathology on the Underestimation of Malignancy for the Incomplete Retrieval of Suspicious Calcifications Diagnosed as Flat Epithelial Atypia or Atypical Ductal Hyperplasia by Stereotactic Vacuum-Assisted Breast Biopsy
por: Yu, Chi-Chang, et al.
Publicado: (2020)

Delineating Novel Signature Patterns of Altered Gene Expression in Schizophrenia Using Gene Microarrays
por: Mirnics, Karoly, et al.
Publicado: (2001)

Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast Cancer
por: Soliman, Hatem, et al.
Publicado: (2020)

Differential Gene Expression in Capsules Derived From Smooth and Textured Silicone Implants
por: Daneshgaran, Giulia, et al.
Publicado: (2019)

A Computational Workflow Translates a 58-Gene Signature to a Formalin-Fixed, Paraffin-Embedded Sample-Based Companion Diagnostic for Personalized Treatment of the BRAF-Mutation-Like Subtype of Colorectal Cancers
por: In’t Veld, Sjors G. J. G., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fbo7t2mk8e15sg1ce6dhdoql32